5-Bromo-1H-indazol-6-ol

Catalog No. :
ACBKNP765
CAS No. :
1227270-50-9
Molecular Formula :
C7H5BrN2O
Molecular Weight :
213.03

IUPAC Name:5-bromo-1H-indazol-6-ol

5-Bromo-1H-indazol-6-ol structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%$77.00Login to see priceIn stockInquiry
500mg97%$145.00Login to see priceIn stockInquiry
1g97%$276.00Login to see priceIn stockInquiry
5g97%$859.00Login to see priceIn stockInquiry
10g97%$1631.00Login to see priceIn stockInquiry
25g97%$3914.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Bromo-1H-indazol-6-ol
IUPAC Name5-bromo-1H-indazol-6-ol
MDL No.MFCD16875808
Molecular FormulaC7H5BrN2O
Molecular Weight213.03
SMILESOC1=CC2=C(C=C1Br)C=NN2
InChI KeySAMGFFSJTFRHJM-UHFFFAOYSA-N
SynonymI10238 | MB15046 | AMY9733 | AS-49435 | 1H-Indazol-6-ol, 5-bromo- | MFCD16875808 | 5-Bromo-1,2-dihydro-6H-indazol-6-one | 5-bromo-1,2-dihydroindazol-6-one | CS-0188047 | AKOS016000746 | SCHEMBL18554004 | 5-Bromo-1H-indazol-6-ol | EN300-6774825 | 5-BROMO-6
CAS No.1227270-50-9
PubChem CID135742438

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACBKNP765 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACRPLI307 route compound structure diagram
    ACRPLI307152626-78-3 In Stock
  2. Then
  3. ACBKNP765 route product structure diagram
    ACBKNP7651227270-50-9 In Stock
Inquiry

2. ACBKNP765 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACBKNP765 route product structure diagram
    ACBKNP7651227270-50-9 In Stock
Inquiry

Comments (0)